AI takes on heart failure: could smart software save lives?

NCT ID NCT07380555

Not yet recruiting Disease control Sponsor: Shanghai Zhongshan Hospital Source: ClinicalTrials.gov ↗

First seen Feb 02, 2026 · Last updated May 24, 2026 · Updated 14 times

Summary

This study tests whether an artificial intelligence (AI) system can help doctors choose the best medications for people with heart failure with reduced ejection fraction (HFrEF). About 1,200 participants from 60 hospitals will be enrolled, with hospitals randomly assigned to use the AI tool or provide standard care. The goal is to see if AI guidance lowers the chance of heart failure hospitalizations or heart-related deaths over 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HF-REF) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shanghai Zhongshan Hospital

Shanghai, Shanghai Municipality, 200032, China

Contact

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEART FAILURE WITH REDUCED EJECTION FRACTION (HF-REF)